What Is EVO ICL Lens?
EVO ICL, also called an Implantable Collamer® Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) and astigmatism. Unlike some other eye correction surgeries, the EVO ICL is an additive technology that corrects vision without removing corneal tissue. Our team of ophthalmologists offers innovative EVO ICL treatments to clients in Michigan and Ohio. The EVO ICL eye surgery will help you reduce or eliminate the need for glasses or contacts and unlike most permanent refractive solutions, EVO ICL is removable. Give our team a call by phone at (877) 852-8463 to become familiar with EVO ICL eye care solutions.
Find Out If You're A Candidate
EVO ICL Procedure - What to Expect
The EVO ICL is surgically implanted by one of our professional ophthalmologists (eye surgeons) and is typically painless with numbing eye drops. The EVO ICL eye surgery is usually less than 20 -30 minutes. After a brief recovery period, the procedure can result in better, clearer eyesight for the patient.
Benefits of EVO ICL Eye Surgery
- Significant vision improvement
- 99% patient satisfaction
- Over 2 million procedures performed worldwide
- Can be removed if needed
- Offers UV protection
- Undetectable once in place
- Can treat astigmatism and myopia
- Maybe an option for patients who are not candidates for other vision correction procedures
- Does not cause dry eye syndrome, which can be a side effect of other eye correction surgeries
- Provides excellent night vision
Eye Care Tips: Sign Up For Cataract Surgery to Improve Your Vision
Eye Care Tips: Talk With Our Staff of Glaucoma Specialists to Receive a Diagnosis
EVO ICL Cost & Financing
The cost of an EVO ICL procedure may differ based on your personalized treatment plan. Numerous EVO ICL recipients anticipate enjoying long-term savings compared to the ongoing expenses associated with contacts and glasses. Contact Specialty Eye Institute about potential financing alternatives and payment arrangements that could be accessible for your EVO ICL procedure.
Schedule Appointment With Our Staff
Important Safety Information for the Visian ICL Product Family
The EVO ICL Visian ICL is indicated for phakic patients 21-45 years of age to correct/reduce myopia with up to 4.00 D of astigmatism with a spherical equivalent ranging fro -3.00 to -20.0D and with an anterior chamber depth (ACD) 3.0mm or greater.
The EVO Visian ICL is contraindicated in patients with a true ACD of <3.00mm, with anterior chamber angle less than Grade III; who have moderate to severe glaucoma, who are pregnant or nursing, less than 21 years of age; and who do not meet the minimum endothelial cell density (ECD)listed in the Directions for Use (DFU).
A summary of the relevant warnings, precautions, and side effects: Endothelial cell loss, corneal edema, cataract, narrowing of the anterior chamber angle, pupillary block, increased intraocular pressure, glaucoma, secondary surgery to reposition, replace or remove the ICL, loss of BSCVA, increase in refractive astigmatism, glare and/or halos, pigment dispersion, iris transillumination defects, endophthalmitis, hypopyon, corneal endothelial damage, ICL dislocation, cystoid macular edema, iritis, retinal detachment, vitritis, and iris prolapse.
Any surgical procedure has risks, and EVO ICL is no exception. Before deciding to proceed with surgery, be sure to review carefully the informed consent document that your physician will give to you which will provide you with the risks, benefits, and alternatives to surgery. 20/20 vision is not guaranteed. Individual results may vary.